Chemed Newsroom

Chemed Is Maintained at Outperform by RBC Capital

Dow JonesApr 28 12:11 ET

Chemed Analyst Ratings

BenzingaApr 28 12:01 ET

Oppenheimer Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $650

Moomoo NewsApr 26 03:31 ET

Chemed (CHE) Gets a Buy From Oppenheimer

TipRanksApr 25 08:24 ET

BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708

Moomoo NewsApr 25 00:32 ET

Chemed's Strong Q1 Performance and Growth Potential Justify Buy Rating

TipRanksApr 24 08:00 ET

BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708

Moomoo NewsApr 15 00:32 ET

Positive Outlook for Chemed's Roto-Rooter Segment Justifies Buy Rating Amid Rising Demand and Revenue Growth

TipRanksApr 14 05:43 ET

RBC Capital Maintains Chemed(CHE.US) With Buy Rating, Raises Target Price to $667

Moomoo NewsMar 15 00:33 ET

Chemed Price Target Raised to $667.00/Share From $633.00 by RBC Capital

Dow JonesMar 14 11:47 ET

Chemed Analyst Ratings

BenzingaMar 14 11:39 ET

RBC Capital Maintains Outperform on Chemed, Raises Price Target to $667

BenzingaMar 14 11:38 ET

BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708

Moomoo NewsFeb 27 07:34 ET

BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708

Moomoo NewsJan 10 06:31 ET

Chemed Maintains Buy Rating Amid Mixed Signals: Resilience in Vitas Segment and Consumer Spending

TipRanksJan 10 05:51 ET

BofA Securities Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $708

Moomoo NewsNov 14, 2024 06:33 ET

Chemed Analyst Ratings

BenzingaNov 5, 2024 11:13 ET

RBC Capital Maintains Chemed(CHE.US) With Buy Rating, Cuts Target Price to $633

Moomoo NewsNov 5, 2024 07:31 ET

RBC Capital Remains a Buy on Chemed (CHE)

TipRanksNov 5, 2024 07:27 ET

Oppenheimer Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $650

Moomoo NewsOct 30, 2024 08:33 ET